Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SENS - Senseonics Holdings Inc


Close
0.3891
0.005   1.259%

Share volume: 1,704,586
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$0.38
0.00
1.28%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
32%
Profitability 39%
Dept financing 23%
Liquidity 75%
Performance 15%
Company vs Stock growth
vs
Performance
5 Days
-7.36%
1 Month
-7.38%
3 Months
-9.95%
6 Months
-44.44%
1 Year
-26.58%
2 Year
-77.51%
Key data
Stock price
$0.39
P/E Ratio 
-2.59
DAY RANGE
$0.38 - $0.39
EPS 
-$0.13
52 WEEK RANGE
$0.36 - $0.75
52 WEEK CHANGE
-$0.31
MARKET CAP 
208.392 M
YIELD 
N/A
SHARES OUTSTANDING 
535.574 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.12
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,448,356
AVERAGE 30 VOLUME 
$1,446,645
Company detail
CEO: Timothy Goodnow
Region: US
Website: https://www.senseonics.com/
Employees: 162
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

senseonics, inc. is a medical device startup company in germantown, maryland, usa (near washington, dc) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. utilizing breakthrough fluorescence sensing technology, the senseonics continuous glucose monitoring ("cgm"​) system is being designed to be the first fully implantable cgm that is highly accurate and stable throughout its long sensor life. the system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.

Recent news